LB Pharmaceuticals Inc

LBRX
$31.68 (+ $0.68 + 2.19%)
Last updated: 2026-06-26 14:40 UTC
LBRX Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS50180M1080
CUSIP50180M108
Market Price31.68
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.74
Market Cap$556.6M
Book Value12.26
Price to Book1.794
BetaN/A
52w High23.15
52w Low13.36
Next Earnings DateN/A

LB Pharmaceuticals Inc trades under ticker LBRX on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US50180M1080, CUSIP 50180M108.

About the Company
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 1 clinical trial for the treatment of bipolar I depression; and in pr clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.
Price History